Avanos Medical, Inc. (NYSE:AVNS) Q3 2022 Earnings Conference Call November 2, 2022 9:00 AM ET

Company Participants

Scott Galovan - Vice President, Corporate Strategy and Business Development

Joseph Woody - Chief Executive Officer

Michael Greiner - Senior Vice President and Chief Financial Officer

Conference Call Participants

Rick Wise - Stifel

Brett Fishbin - KeyBanc

Operator

Good morning, and welcome to the Avanos Third Quarter 2022 Earnings Conference Call. [Operator Instructions] Please note, this event is being recorded.

I would now like to turn the conference over to Scott Galovan. Please go ahead.

Scott Galovan

Good morning, everyone, and thanks for joining us. It's my pleasure to welcome you to the Avanos 2022 third quarter earnings conference call. Presenting today will be Joe Woody, CEO; and Michael Greiner, Senior Vice President and CFO. Joe will review our quarter and current business environment as well as provide an update on our key objectives for 2022. Then Michael will discuss additional detail regarding our third quarter and review our 2022 planning assumptions. We will finish the call with Q&A. A presentation for today's call is available on the Investors section of our website, avanos.com.

As a reminder, our comments today contain forward-looking statements related to the company, our expected performance, current economic conditions and our industry. No assurance can be given as to future financial results. Actual results could differ materially from those in the forward-looking statements. For more information about forward-looking statements and the risk factors that could influence future results, please see today's press release and risk factors described in our filings with the SEC. Additionally, we will be referring to adjusted results and outlook. The press release has information on these adjustments and reconciliations to comparable GAAP financial measures.

Now I'll turn the call over to Joe.

Joseph Woody

Thanks, Scott. Good morning, everyone, and thank you for joining us to review our operational and financial results for the third quarter of 2022. Our operational and commercial teams continue to execute well in this dynamic and uneven environment, which supports us maintaining our full year guidance ranges.

The demand for our products remain strong, and we continue to manage supply chain disruptions to mitigate the impact of our persistent backorder challenges. Despite these challenges, we were still able to deliver strong operating and EBITDA margin results, along with consistent free cash flow generation that's now almost $80 million over the trailing four quarters.